Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Illumina Inc (ILMN-RM)

Moscow
Currency in RUB
Disclaimer
26,008.00
0.00(0.00%)
Closed

ILMN-RM Comments

There is no way it would go up from here (100)
50$ soon
Get in to this stock before it's too late, it's only trading at P/E Ratio -1,530.59. LOL LOL
looks like a good buy to throw a little in
https://www.bloomberg.com/news/articles/2021-11-29/omicron-tests-biden-s-1-7-billion-plan-to-better-track-variants
what is comante
should i hold?
why Illumina corrected after this great earnings?
I think for the next EU fine on Grail acquisition
IS IT AWEFUL?
t
should rise on earnings
yeah "should"
If the trial of Grail's Galeri test with the NHS is a success this stock is going to fly into the stratosphere. Imagine getting an early cancer test with your run of the mill blood draw at the doctors office. Billions in sales per month, millions of lives saved and reduced overall medical expenses. Watching this guy closely.
Lol why keep falling tf
when the share price go to 550 and above? i am waiting to sell my stock.
ah too expensive bubble
SNDL very cheap drugs company 0.51 USD that will reach 2 or 3 USD.. Other Drugs like Aurora reach 6USD.. Buying 5K shares and hold it is very good idea.. Good luck guys..
Good call its right at $2.09 today.
Wow, goes up everyday kind of stock, nice.
Looking at all the downgrade today, it looks like nobody liked the fact Ilmn bought back something they  span off not long ago for 20% of their market cap, pretty amazingly they still went ahead and finish the deal. This Grail has to be really good, otherwise, the CEO's door is for him to exit.
see 150
Next stop 275, if not held, it will visit 200 March low. I don't think the recent drop is entirely Grail acquisition related. Sellers just use that as excuses. Two days down 8% each on very heavy volume, finished days at low,..
Heavy volume? Its been averaging 1 mil of less only today was its volume above 4 million
Rather than bying Grail they should buy Guardant!
On the way to make an acquisition, so it drops- I prefer Guardant even if expensive but they receive FDA approval both for covid test and cancer detectio liquid bloodtest
too expensive
Expensive for several reasons:  1) 70% of market share 2) consistently grow except during the pandemic 3) huge potential of the genetic field I'd love to see it drop to 200 again, but it will probably never see that price again unless they do a stock split.
why it dropped so much so fast?
Sundial growers next week 1,5 $
2019 july this stock drop 14%, same like today. looks like if wont hold 200 ema. usually sell off happen one or two days, not end in one day. high risk
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.